PennyOmega.com Stock Report! 8/26/09, PRGS, Q, RX, NYMX, MDS, UNCA

Source: http://pennyomega.com/?p=804
Posted on Wednesday, August 26th, 2009 | In Market Commentary, Stocks to Watch

Contributed by: Penny Omega (http://pennyomega.com) -

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Wednesday August 26, 2009

PennyOmega.com Stock Report!

**************************************************************

Progress DataDirect (www.datadirect.com), the data infrastructure division of Progress Software Corporation (NASDAQ: PRGS) and provider of premium, vendor-independent data access and integration technologies for all major data sources has announced it will be hosting a series of free workshops to help system architects, software programmers and IT professionals interested in data access and data integration best practices.

Gulfstream Aerospace recently recognized Qwest Communications (NYSE: Q) as a top-performing supplier for its design and delivery of an integrated voice and data wide area network (WAN) connecting the aerospace company’s locations in the United States and internationally.

IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, has received the endorsement of the National Quality Forum (NQF) for two of its clinical quality indicators for measuring medication usage and patient adherence. The IMS measures address the use of antipsychotics by patients with schizophrenia, and medications used by patients with coronary artery disease. Consensus standards endorsed by NQF are used for measuring and publicly reporting on the performance of different aspects of the U.S. healthcare system, and are widely viewed as the “gold standard” for the measurement of healthcare quality.

Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce that NX-1207, the Company’s lead drug in development, has been shown to repeatedly produce strongly positive results when given to animals with hepatocellular carcinoma (HCC). In the experimental studies, the cancers were significantly reduced in size after 2 local injections of NX-1207. The rodents in the studies had transplanted human HCC, a standard model for cancer research. These animals had an average tumor burden reduction of close to 50% after 20 days. The NX-1207 used in these studies is a different formulation and a higher dosage from that of NX-1207 used to treat benign prostatic hyperplasia (BPH).

Midas, Inc. (NYSE: MDS) has brought the well-known Northern California SpeeDee Oil Change name to San Diego by adding SpeeDee quick-lube services to 11 company-owned Midas shops in the San Diego market.

Unica Corporation (NASDAQ: UNCA), the recognized leader in marketing software solutions, today announced the successful conclusion of its inaugural Asia/Pacific Customer Summit in Sydney, Australia. The Summit was attended by nearly one hundred of the region’s leading marketers, who heard about the latest advancements in interactive marketing.

***********Advertisement***********

promo

********************************

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more ) Rule 17B requires disclosure of payment for investor relations.

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<